|
Volumn 11, Issue SUPPL. 1, 2001, Pages 55-59
|
Thrombolysis in ischaemic stroke - Present and future: Role of combined therapy
|
Author keywords
Combined therapy; Neuroprotecting agents; Stroke; Thrombolysis; Tissue plasminogen activator
|
Indexed keywords
FIBRINOLYTIC AGENT;
LUBELUZOLE;
RT PA;
UNCLASSIFIED DRUG;
ANTICOAGULATION;
BLEEDING;
BLOOD CLOT LYSIS;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST CONTROL;
DISEASE COURSE;
DRUG DEPENDENCE;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
MAJOR CLINICAL STUDY;
META ANALYSIS;
MORTALITY;
NEUROPROTECTION;
PATIENT SELECTION;
PRIORITY JOURNAL;
BRAIN ISCHEMIA;
CEREBROVASCULAR ACCIDENT;
DRUG THERAPY, COMBINATION;
FIBRINOLYTIC AGENTS;
HUMANS;
NEUROPROTECTIVE AGENTS;
THROMBOLYTIC THERAPY;
TISSUE PLASMINOGEN ACTIVATOR;
|
EID: 0035105713
PISSN: 10159770
EISSN: None
Source Type: Journal
DOI: 10.1159/000049126 Document Type: Conference Paper |
Times cited : (36)
|
References (33)
|